Justin J. File, Chief Financial Officer at Evofem Biosciences, Inc. (EVFM), sold 3,352 shares at $6.05 ($20K) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Scheduled sale ($20k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EVFM | BUY | 2020-11-18 | $17K | — | Filing → |
| EVFM | BUY | 2020-06-15 | $27K | — | Filing → |
| EVFM | SELL | 2020-01-15 | $10K | — | Filing → |